On Feb 21, 2022 Engimmune Therapeutics closed a Series A round and raised CHF500,000 from BaseLaunch, featuring lead investors BaseLaunch.
About the company: Engimmune Therapeutics is located at Switzerland, Europe.
“”
Company website: http://www.engimmune.com